Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Sep 2023
Historique:
received: 18 07 2023
revised: 16 08 2023
accepted: 28 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Diabetic nephropathy (DN), as the one of most common complications of diabetes, is generally diagnosed based on a longstanding duration, albuminuria, and decreased kidney function. Some patients with the comorbidities of diabetes and other primary renal diseases have similar clinical features to DN, which is defined as non-diabetic renal disease (NDRD). It is necessary to distinguish between DN and NDRD, considering they differ in their pathological characteristics, treatment regimes, and prognosis. Renal biopsy provides a gold standard; however, it is difficult for this to be conducted in all patients. Therefore, it is necessary to discover non-invasive biomarkers that can distinguish between DN and NDRD. In this research, the urinary exosomes were isolated from the midstream morning urine based on ultracentrifugation combined with 0.22 μm membrane filtration. Data-independent acquisition-based quantitative proteomics were used to define the proteome profile of urinary exosomes from DN (n = 12) and NDRD (n = 15) patients diagnosed with renal biopsy and Type 2 diabetes mellitus (T2DM) patients without renal damage (n = 9), as well as healthy people (n = 12). In each sample, 3372 ± 722.1 proteins were identified on average. We isolated 371 urinary exosome proteins that were significantly and differentially expressed between DN and NDRD patients, and bioinformatic analysis revealed them to be mainly enriched in the immune and metabolic pathways. The use of least absolute shrinkage and selection operator (LASSO) logistic regression further identified phytanoyl-CoA dioxygenase domain containing 1 (PHYHD1) as the differential diagnostic biomarker, the efficacy of which was verified with another cohort including eight DN patients, five NDRD patients, seven T2DM patients, and nine healthy people. Additionally, a concentration above 1.203 μg/L was established for DN based on the ELISA method. Furthermore, of the 19 significantly different expressed urinary exosome proteins selected by using the protein-protein interaction network and LASSO logistic regression, 13 of them were significantly related to clinical indicators that could reflect the level of renal function and hyperglycemic management.

Identifiants

pubmed: 37686366
pii: ijms241713560
doi: 10.3390/ijms241713560
pmc: PMC10488032
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : The National Science Foundation of China
ID : 61971441
Organisme : The National Science Foundation of China
ID : 62271506
Organisme : the National Key R&D Program of China
ID : 2021YFC1005300
Organisme : the National Key R&D Program of China
ID : 2021YFC1005302

Références

Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
Diabetes Care. 2022 Jan 1;45(Suppl 1):S175-S184
pubmed: 34964873
Semin Cancer Biol. 2022 Nov;86(Pt 1):64-79
pubmed: 34509614
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
J Proteomics. 2014 Jan 16;96:92-102
pubmed: 24211404
Science. 2020 Feb 7;367(6478):
pubmed: 32029601
Mol Cell Proteomics. 2023 Apr;22(4):100514
pubmed: 36796643
J Hematol Oncol. 2022 Jun 28;15(1):83
pubmed: 35765040
J Extracell Vesicles. 2021 May;10(7):e12093
pubmed: 34035881
Diabetes Care. 2006 Apr;29(4):853-7
pubmed: 16567827
Cell Death Dis. 2021 Feb 8;12(2):160
pubmed: 33558472
J Diabetes Res. 2016;2016:5741518
pubmed: 28105442
J Extracell Vesicles. 2022 Apr;11(4):e12200
pubmed: 35362259
Kidney Int. 2004 Dec;66(6):2374-81
pubmed: 15569329
Diab Vasc Dis Res. 2012 Oct;9(4):301-8
pubmed: 22388283
Curr Biol. 2018 Apr 23;28(8):R435-R444
pubmed: 29689228
J Extracell Vesicles. 2019 Apr 01;8(1):1596016
pubmed: 30988894
Nat Rev Endocrinol. 2017 Jan;13(1):36-49
pubmed: 27636730
Adv Sci (Weinh). 2020 Nov 27;8(1):2003505
pubmed: 33437589
Signal Transduct Target Ther. 2020 Nov 24;5(1):273
pubmed: 33235217
EBioMedicine. 2022 Feb;76:103808
pubmed: 35065421
Biochem Biophys Res Commun. 2011 May 20;408(4):553-8
pubmed: 21530488
Nat Rev Nephrol. 2017 Dec;13(12):731-749
pubmed: 29081510
Kidney Int. 2010 Apr;77(8):736-42
pubmed: 20130532
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
Cell Mol Life Sci. 2021 Apr;78(7):3265-3283
pubmed: 33507324
Cell Metab. 2014 Mar 4;19(3):380-92
pubmed: 24508507
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
J Diabetes Res. 2015;2015:289734
pubmed: 25874235
Minerva Med. 2018 Apr;109(2):116-125
pubmed: 29115800
Membranes (Basel). 2022 Dec 08;12(12):
pubmed: 36557150
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
J Pineal Res. 2018 Sep;65(2):e12493
pubmed: 29607540
Cell Mol Life Sci. 2009 Mar;66(5):773-87
pubmed: 19011757
Lancet. 2020 Feb 29;395(10225):662-664
pubmed: 32061314
J Am Soc Nephrol. 2012 Mar;23(3):458-69
pubmed: 22223877
Dev Cell. 2019 Dec 2;51(5):575-586.e4
pubmed: 31735663
Nature. 2020 Sep;585(7826):603-608
pubmed: 32939090
J Am Soc Nephrol. 2010 Mar;21(3):438-47
pubmed: 20056746
Nat Rev Mol Cell Biol. 2020 Jan;21(1):4-5
pubmed: 31748716
J Adv Res. 2020 Jan 22;23:163-205
pubmed: 32154036
Science. 2020 Aug 21;369(6506):1005-1010
pubmed: 32616672
Eur J Pharm Sci. 2017 Feb 15;98:70-79
pubmed: 27751843
J Am Soc Nephrol. 2009 Feb;20(2):363-79
pubmed: 19056867
J Mol Biol. 2021 May 28;433(11):166747
pubmed: 33310018
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Nutr Diabetes. 2021 Jun 30;11(1):24
pubmed: 34193814
Clin J Am Soc Nephrol. 2013 Oct;8(10):1718-24
pubmed: 23886566
J Am Soc Nephrol. 2010 Apr;21(4):556-63
pubmed: 20167701
J Proteomics. 2015 Jan 01;112:53-62
pubmed: 25123350
Diabetes. 2017 May;66(5):1391-1404
pubmed: 28289043
Biochem Biophys Res Commun. 2016 Apr 8;472(3):551-6
pubmed: 26970303
Int J Mol Sci. 2020 Sep 04;21(18):
pubmed: 32899828
J Immunol. 2019 Jun 15;202(12):3483-3492
pubmed: 31061008
Signal Transduct Target Ther. 2023 Mar 27;8(1):121
pubmed: 36967385
Mil Med Res. 2021 Nov 8;8(1):56
pubmed: 34743730
Signal Transduct Target Ther. 2023 Apr 10;8(1):152
pubmed: 37037849
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73
pubmed: 15326289
Front Endocrinol (Lausanne). 2022 Aug 11;13:866252
pubmed: 36034457

Auteurs

Xiaonan Ding (X)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.
Medical School of Chinese People's Liberation Army, Beijing 100853, China.

Dong Zhang (D)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Qinqin Ren (Q)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Yilan Hu (Y)

Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Jifeng Wang (J)

Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Jing Hao (J)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Haoran Wang (H)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Xiaolin Zhao (X)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Xiaochen Wang (X)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Chenwen Song (C)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Junxia Du (J)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Fuquan Yang (F)

Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Hanyu Zhu (H)

Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH